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Abstract: 
Introduction: Novel methods of identifying individuals at risk for atrial fibrillation (AF) are needed. 
MicroRNAs (MiRNAs) regulate gene expression in a number of cardiovascular diseases, including AF. It is 
unknown, however, if key circulating, cardiac-specific miRNAs differ between individuals with 
paroxysmal or persistent AF and those in sinus rhythm.  
Methods: 17 individuals with a history of AF were recruited prior to catheter ablation. 24 hospitalized 
patients in normal sinus rhythm and no history of AF comprised the control group. 94 plasma miRNAs 
were selected based on a priori associations with processes implicated in AF for evaluation using the 
TaqMan miRNA expression profiling system. 
Results: We found that miRNA expression differed by at least 2-fold for 14 miRNAs, including several 
previously implicated in cardiovascular remodeling and disease (Figure 1). Levels of miR-7, miR-208, and 
miR-302b were statistically significantly up- or down-regulated in AF patients relative to controls 
(p<0.05) and levels of miR-218 differed by greater than 20-fold (p=0.095).  
Application: Although power was limited by the modest sample size, these data support the rationale 
for using circulating miRNA as AF biomarkers. Moreover, since miRNA can modulate disease pathways, 
miRNA-based therapeutics would theoretically enable targeting of novel gene regulatory pathways 
implicated in AF in a unique and powerful manner.  
Next Steps/ Future:
 
 Further investigations involving well-characterized, large samples from longitudinal 
studies with standardized miRNA assessment and evaluation for AF are required to validate the 
observed associations.  
 
